scholarly article | Q13442814 |
P2093 | author name string | James W Perfield | |
Sarah L Giesy | |||
Yves R Boisclair | |||
Katie M Schoenberg | |||
Luciano S Caixeta | |||
Anthony Butterfield | |||
Christopher S Krumm | |||
Donald Clarence Beitz | |||
P2860 | cites work | Human HMGCS2 regulates mitochondrial fatty acid oxidation and FGF21 expression in HepG2 cell line | Q24608087 |
BetaKlotho is required for metabolic activity of fibroblast growth factor 21 | Q24681531 | ||
Regulation of organic nutrient metabolism during transition from late pregnancy to early lactation | Q40959412 | ||
FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho | Q42819634 | ||
Chronic metabolic responses of postpartal dairy cows to subcutaneous glucagon injections, oral glycerol, or both | Q42959889 | ||
Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin. | Q43083741 | ||
Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice | Q43224118 | ||
Decreased concentration of plasma leptin in periparturient dairy cows is caused by negative energy balance. | Q43787421 | ||
Production Responses of Dairy Cows to Dietary Supplementation with Conjugated Linoleic Acid (CLA) During the Transition Period and Early Lactation | Q44639965 | ||
Performance and metabolic and endocrine changes with emphasis on glucose metabolism in high-yielding dairy cows with high and low fat content in liver after calving | Q46078088 | ||
Acute metabolic responses of postpartal dairy cows to subcutaneous glucagon injections, oral glycerol, or both. | Q46395365 | ||
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. | Q46445480 | ||
Influence of growth hormone on circulating fibroblast growth factor 21 levels in humans | Q48026201 | ||
Dry period plane of energy: Effects on glucose tolerance in transition dairy cows. | Q53262343 | ||
Lipolysis in subcutaneous and perirenal adipose tissue from sheep and dairy steers | Q67586577 | ||
Response of plasma leptin concentration to jugular infusion of glucose or lipid is dependent on the stage of lactation of Holstein cows | Q79339508 | ||
Prevention of fatty liver in transition dairy cows by subcutaneous injections of glucagon | Q83136708 | ||
Prepartum dietary energy intake affects metabolism and health during the periparturient period in primiparous and multiparous Holstein cows | Q83455555 | ||
Roles of FGF Signals in Heart Development, Health, and Disease | Q28072691 | ||
Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis? | Q28571194 | ||
Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes | Q28571616 | ||
The glucagon receptor is required for the adaptive metabolic response to fasting | Q28594780 | ||
Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states | Q29615208 | ||
Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 | Q29615209 | ||
Thyroid hormone regulation of metabolism | Q33707954 | ||
Adaptations of glucose metabolism during pregnancy and lactation | Q33959384 | ||
Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis | Q34019712 | ||
Plasma FGF21 is elevated by the intense lipid mobilization of lactation | Q34223326 | ||
Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes | Q35266423 | ||
Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets | Q36061647 | ||
Lipid metabolism during lactation: a review of adipose tissue-liver interactions and the development of fatty liver | Q36285506 | ||
Metabolic fibroblast growth factors (FGFs): Mediators of energy homeostasis | Q36746670 | ||
Fibroblast growth factor 21 mediates specific glucagon actions | Q36796145 | ||
Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease | Q36889026 | ||
CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis | Q37005595 | ||
A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism. | Q37571422 | ||
Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor α to regulate metabolic hormone FGF21. | Q37594100 | ||
Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease | Q37781747 | ||
Hormone-like fibroblast growth factors and metabolic regulation | Q37866879 | ||
The role of hepatokines in metabolism | Q38075770 | ||
Insulin resistance in dairy cows | Q38117866 | ||
PPARalpha is a key regulator of hepatic FGF21. | Q38300403 | ||
Systemic Nutrient and Stress Signaling via Myokines and Myometabolites | Q38623031 | ||
Understanding the Physiology of FGF21. | Q38665376 | ||
FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms | Q38852382 | ||
The New Biology and Pharmacology of Glucagon. | Q38919742 | ||
Adipose crosstalk with other cell types in health and disease | Q39256570 | ||
Increased plasma leptin attenuates adaptive metabolism in early lactating dairy cows. | Q39936768 | ||
P921 | main subject | fatty acid | Q61476 |
glucagon | Q28163629 | ||
P304 | page(s) | ajpregu.00197.2017 | |
P577 | publication date | 2017-08-09 | |
P1433 | published in | American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | Q2201819 |
P1476 | title | Effect of circulating glucagon and free fatty acids on hepatic FGF21 production in dairy cows |